iCAD, Inc.'s Strategic Partnership With Advanced Rad Solutions Expands Availability of the Xoft System Into Dermatology Centers

Published: Sep 12, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced a strategic partnership with Advanced Rad Solutions (ARS) to place iCAD’s Xoft® Axxent® Electronic Brachytherapy Systems® at ARS sites to treat patients diagnosed with non-melanoma skin cancer (NMSC). ARS is a full-service integrator of radiation therapies into treatment centers and physician practices. As part of the strategic partnership, the Xoft System will be used at each of ARS’ affiliated dermatology sites, beginning with its California sites, allowing patients to undergo electronic brachytherapy treatment in the convenience of a dermatologist’s office.

Help employers find you! Check out all the jobs and post your resume.

Back to news